MindMed to Present at Upcoming May Medical ConferencesBusiness Wire • 1 day ago
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today...
Share to Feed
Shares of Mind Medicine (MindMed) Inc. MNMD have skyrocketed 154% in the past three months against the industry's decline of 4.2%.The company is progressing well with the development of its lead...
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) hit a new 52-week high during trading on Wednesday . The company traded as high as $11.85 and last traded at $11.69, with a...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) traded down 1.7% during trading on Tuesday . The stock traded as low as $8.97 and last traded at $9.36. 489,301 shares changed...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the Company or MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report)'s share price traded up 4.5% during trading on Thursday . The stock traded as high as $9.94 and last traded at $9.93. 617,016 shares...
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD Get Free Report) insider Dan Karlin sold 6,578 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average...
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD Get Free Report) were down 1.1% during trading on Friday . The company traded as low as $9.26 and last traded at $9.40. Approximately...
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD Get Free Report) insider Dan Karlin sold 6,578 shares of the businesss stock in a transaction that occurred on Monday, March 25th. The stock...